Breath Test for Women Receiving Tamoxifen in the Prevention or Treatment of Breast Cancer

TerminatedOBSERVATIONAL
Enrollment

92

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

September 23, 2015

Study Completion Date

September 23, 2015

Conditions
Breast Cancer
Interventions
DRUG

dextromethorphan hydrobromide

DRUG

tamoxifen citrate

OTHER

high performance liquid chromatography

OTHER

laboratory biomarker analysis

OTHER

pharmacogenomic studies

OTHER

pharmacological study

PROCEDURE

fluorescence imaging

Trial Locations (2)

55905

Mayo Clinic, Rochester

Unknown

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER